Antibody Drug Conjugates Market
Antibody Drug Conjugates Market Size, Share & Trends Analysis Report
Antibody Drug Conjugates Market Size, Share, Statistics & Trends Analysis By Product Type, By Application, By Payload Type, By Linker Type, By End User, By Region, And Segment Forecasts, 2026 – 2032
Published
Report ID : BMRC 3800
Number of pages : 300
Published Date : Jun 2026
Category : Healthcare
Delivery Timeline : 48 hrs
Market Segmentation
By Product
- Enhertu
- Kadcyla
- Adcetris
- Trodelvy
- Polivy
- Padcev
- Others
By Application
- Breast Cancer
- Blood Cancer
- Leukemia
- Lymphoma
- Urothelial Carcinoma
- Ovarian Cancer
- Lung Cancer
- Other Cancers
By Payload Type
- Auristatins
- Maytansinoids
- Camptothecin Derivatives
- Others
By Linker Type
- Cleavable Linkers
- Non-Cleavable Linkers
By End User
- Hospitals
- Specialty Cancer Centers
- Research Institutes
- Biotechnology Companies
Key Players
- AstraZeneca plc
- Daiichi Sankyo Company Limited
- Pfizer Inc.
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences Inc.
- Seagen Inc.
- Takeda Pharmaceutical Company Limited
- ADC Therapeutics SA
- AbbVie Inc.
- Astellas Pharma Inc.
- GSK plc
SUMMARY
Segments
Market Segmentation
By Product
- Enhertu
- Kadcyla
- Adcetris
- Trodelvy
- Polivy
- Padcev
- Others
By Application
- Breast Cancer
- Blood Cancer
- Leukemia
- Lymphoma
- Urothelial Carcinoma
- Ovarian Cancer
- Lung Cancer
- Other Cancers
By Payload Type
- Auristatins
- Maytansinoids
- Camptothecin Derivatives
- Others
By Linker Type
- Cleavable Linkers
- Non-Cleavable Linkers
By End User
- Hospitals
- Specialty Cancer Centers
- Research Institutes
- Biotechnology Companies
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
Key Players
- AstraZeneca plc
- Daiichi Sankyo Company Limited
- Pfizer Inc.
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences Inc.
- Seagen Inc.
- Takeda Pharmaceutical Company Limited
- ADC Therapeutics SA
- AbbVie Inc.
- Astellas Pharma Inc.
- GSK plc
